We’ve seen several Israeli firms and lawyers being nominated for European awards in 2026 and, continuing that trend, the following firms have been shortlisted for Israel Firm of the Year: Agmon with Tulchinsky, AYR – Amar Reiter Jeanne Shochatovitch & Co., Cohn de Vries Stadler & Co., Erdinast Ben Nathan, Toledano, Gornitzky GNY, Herzog, H-F & Co., and S Friedman Abramson & Co.

The awards, organized by IFLR, highlight professional excellence and contributions to advancing diversity and inclusion across the legal industry. Winners are expected to be announced at a ceremony scheduled for June 25, 2026.

Read more here.

The post IFLR Publishes 2026 Women in Business Law Shortlist appeared first on IsraelDesks.

The session will address practical challenges facing in-house counsel, including issues related to the National Health Insurance Law and statutory responsibilities that shape decision-making within organizations, among other relevant items.

The discussion will be led by partner Nili Hayoun Dickman, who will share practical insights on managing legal risk and navigating day-to-day compliance considerations in a complex regulatory environment.

Register here.

The post Shibolet, ACC to host webinar on legal and regulatory challenges in pharma sector appeared first on IsraelDesks.

The case, originally filed in 2018, alleged that Facebook allowed third-party apps to access users’ personal data without proper consent and transfer it for political targeting purposes. Meta denied wrongdoing, arguing users had agreed to the platform’s data practices and that limited harm occurred in Israel.

The court approved the settlement in part due to changes Meta implemented to its data policies and the difficulty of proving direct harm to Israeli users. The funds will be directed toward public initiatives, including academic research and programs related to democracy and digital literacy.

Read more in Ynet.

The post Meta to pay NIS8.1m in Israel over Cambridge Analytica data scandal appeared first on IsraelDesks.

The combination will bring together SoundHound’s voice and agentic AI capabilities with LivePerson’s digital messaging and customer engagement platform, creating a unified omnichannel conversational AI solution serving enterprises across industries. SoundHound expects the transaction to expand its global footprint and enterprise customer base, with the combined business operating across more than 30 countries and serving major corporate clients.

SoundHound was represented by Latham & Watkins, with Herzog acting as Israeli advisor on the deal. The Herzog team was led by partners Ron Ben-Menachem, Mohammad Mawasi, Shachar Porat, Orly Katzir, and Adar Bengom (Ortal).

Fried Frank acted for LivePerson.

The post SoundHound AI to acquire LivePerson in USD43m deal appeared first on IsraelDesks.

Epstein Rosenblum Maoz advised Phoenix on the transaction, with the team being led by Ron Abelski, together with Michal Gazit Molcho and intern Talia Sigad.

Adeltech was represented by Mike Rimon and Doreen Pendos of Meitar, while Firon acted for Menora Mivtachim.

The post Phoenix sells stake in Dorad Energy valued at NIS4.46b appeared first on IsraelDesks.

The company is focused on building a quantum computing platform based on trapped-ion technology, an approach widely viewed as one of the more stable and scalable architectures in the race toward commercially viable quantum systems.

The new capital will support continued development of its core hardware as Quantum Art advances its engineering and system capabilities.

Erdinast, Ben Nathan, Toledano advised Quantum Art on the transaction, led by partner Amir Gruber and senior associate Yosef Mark, together with Rachel Grin.

The post Quantum Art extends Series A to USD140m appeared first on IsraelDesks.

Lee Noyek, head of the firm’s Israel Desk, echoes this sentiment, saying the report examines why life sciences and healthcare companies are attracting heightened attention from activist funds and what boards can do in response.

It also shows how with AI-driven partnerships, acquisitions, and collaborations gathering pace, quality, consent, ownership, and regulatory compliance are increasingly central to deal value and risk allocation. Furthermore, he explains, it analyzes global developments from the deal structures Chinese innovators are using to expand internationally, as well as how the UPC is impacting European patent litigation two years after its launch.

For Israeli firms — combining decades-old digital health infrastructure with world-class computational biology talent and increasingly seeking international partnerships — each of these themes lands with particular force: activist scrutiny as funding rounds grow larger, AI data governance as deal-making accelerates, and China and European patent dynamics as global expansion becomes the next frontier.

Read the report here.

The post A&O Shearman publishes Life Sciences and Healthcare report appeared first on IsraelDesks.

The round—led by Drive Capital with participation from investors including Access Industries, Fidelity, NEA, and Nvidia—reflects growing investor focus on companies building the underlying infrastructure powering AI systems. A significant portion of the funds will go toward liquidity for early investors and employees.

Skadden represented Vast Data, with H-F & Co. acting as Israeli counsel.

The post Vast Data reaches USD30b valuation in latest funding round appeared first on IsraelDesks.

The conference is expected to convene investors, corporates, startups, and ecosystem leaders to explore partnerships across AI, DefenseTech, Cyber, HealthTech, FoodTech, Industry 4.0, and ClimateTech. Continued participation in the conference by European partners, sponsors, and speakers underscores their sustained interest in collaboration with Israel’s innovation ecosystem and signals long-term commitment between the German, Swiss, Austrian, and Israeli tech communities.

Register here.

The post Europe Days Conference in Tel Aviv scheduled for October 20, 2026 appeared first on IsraelDesks.

The program requires collaboration between two unrelated companies—one registered in the United States and one in Israel—and targets innovation with clear commercial potential across sectors including cybersecurity, fintech, life sciences, energy, and agri-tech. For in-house teams and outside counsel, the call can also be a timely prompt to review cross-border structuring, IP ownership and licensing, commercialization rights, and compliance mechanics before submission.

Executive summaries are due May 14, 2026, and full proposals are due July 9, 2026.

Learn more here.

The post BIRD opens new call offering up to USD1.5m for US–Israel joint R&D projects appeared first on IsraelDesks.